Trials / Unknown
UnknownNCT05671575
Study The Knowledge and Attitude Towards Epilepsy Among Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life
A Study of The Knowledge and Attitude Towards Epilepsy Among Close Relatives of People With Epilepsy and Their Impact on The Patient's Quality of Life
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Mohamed Adel Abdellah · Academic / Other
- Sex
- All
- Age
- 16 Years – 110 Years
- Healthy volunteers
- Accepted
Summary
Epilepsy is a common neurological condition that affects personal and familial behavior and social support . About 50 million people worldwide suffer from epilepsy and the prevalence of active epilepsy in developing countries is 5 to 10 per 100 persons . Individuals with epilepsy may suffer from psychological issues such as depression, anxiety, and psychosis . Accordingly, living with a person with epilepsy will provide some challenges, particularly at home. Studies have reported that relatives of people with epilepsy have an increased risk of anxiety. Epilepsy can inflict an enormous burden on both the people with epilepsy (PWE) and their family caregivers, decreasing their quality of life and daily efficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire about Epilepsy | After obtaining informed consent, a structured questionnaire will be administered to the accompanying relative. The questionnaire consists of 5 sections: participants socio-demographic characteristics, patient demographic and clinical characteristics, participants knowledge about epilepsy including sources of knowledge and management of an acute seizure, general attitudes, and behaviors towards the People with epilepsy, Stigma scale of epilepsy.\[14\], and Quality of life in epilepsy-10 inventory (QOLIE-10) as the main data collection tool as regard quality of life of patients with epilepsy. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2024-01-01
- Completion
- 2024-01-01
- First posted
- 2023-01-04
- Last updated
- 2023-01-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05671575. Inclusion in this directory is not an endorsement.